Pathogens (May 2020)
Clinical Outcomes of a Zika Virus Mother–Child Pair Cohort in Spain
- Antoni Soriano-Arandes,
- Marie Antoinette Frick,
- Milagros García López-Hortelano,
- Elena Sulleiro,
- Carlota Rodó,
- María Paz Sánchez-Seco,
- Marta Cabrera-Lafuente,
- Anna Suy,
- María De la Calle,
- Mar Santos,
- Eugenia Antolin,
- María del Carmen Viñuela,
- María Espiau,
- Ainara Salazar,
- Borja Guarch-Ibáñez,
- Ana Vázquez,
- Juan Navarro-Morón,
- José-Tomás Ramos-Amador,
- Andrea Martin-Nalda,
- Eva Dueñas,
- Daniel Blázquez-Gamero,
- Resurrección Reques-Cosme,
- Iciar Olabarrieta,
- Luis Prieto,
- Fernando De Ory,
- Claire Thorne,
- Thomas Byrne,
- Anthony E. Ades,
- Elisa Ruiz-Burga,
- Carlo Giaquinto,
- María José Mellado-Peña,
- Alfredo García-Alix,
- Elena Carreras,
- Pere Soler-Palacín
Affiliations
- Antoni Soriano-Arandes
- Paediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
- Marie Antoinette Frick
- Paediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
- Milagros García López-Hortelano
- Department of Paediatrics, Hospital Universitario La Paz, 28046 Madrid, Spain
- Elena Sulleiro
- Departament of Microbiology, Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain
- Carlota Rodó
- Unit of Fetal Medicine, Department of Obstetrics, Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain
- María Paz Sánchez-Seco
- Instituto de Salud Carlos III, 28029 Madrid, Spain
- Marta Cabrera-Lafuente
- Department of Neonatology, Hospital Universitario La Paz, 28046 Madrid, Spain
- Anna Suy
- Unit of Fetal Medicine, Department of Obstetrics, Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain
- María De la Calle
- Department of Obstetrics, Hospital Universitario La Paz, 28046 Madrid, Spain
- Mar Santos
- Department of Paediatrics, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain
- Eugenia Antolin
- Department of Obstetrics, Hospital Universitario La Paz, 28046 Madrid, Spain
- María del Carmen Viñuela
- Department of Obstetrics, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain
- María Espiau
- Paediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
- Ainara Salazar
- Paediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
- Borja Guarch-Ibáñez
- Department of Paediatrics, Hospital Universitari Josep Trueta, 17007 Girona, Spain
- Ana Vázquez
- Instituto de Salud Carlos III, 28029 Madrid, Spain
- Juan Navarro-Morón
- Hospital Costa del Sol, 29603 Marbella, Spain
- José-Tomás Ramos-Amador
- Department of Paediatrics, Hospital Universitario Clínico San Carlos, 28040 Madrid, Spain
- Andrea Martin-Nalda
- Paediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
- Eva Dueñas
- Department of Paediatrics, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain
- Daniel Blázquez-Gamero
- Pediatric Infectious Diseases Unit, Hospital Universitario 12 de Octubre, Madrid, Instituto de Investigación Hospital 12 de Octubre (imas12), Universidad Complutense, 28041 Madrid, Spain
- Resurrección Reques-Cosme
- Hospital El Escorial, 28200 Madrid, Spain
- Iciar Olabarrieta
- Hospital Severo Ochoa, Leganés, 28911 Madrid, Spain
- Luis Prieto
- Pediatric Infectious Diseases Unit, Hospital Universitario 12 de Octubre, Madrid, Instituto de Investigación Hospital 12 de Octubre (imas12), Universidad Complutense, 28041 Madrid, Spain
- Fernando De Ory
- Instituto de Salud Carlos III, 28029 Madrid, Spain
- Claire Thorne
- University College London Great Ormond Street Institute of Child Health, GOSH NIHR BRC, London WC1N 1EH, UK
- Thomas Byrne
- University College London Great Ormond Street Institute of Child Health, GOSH NIHR BRC, London WC1N 1EH, UK
- Anthony E. Ades
- University of Bristol, Bristol BS9 1AF, UK
- Elisa Ruiz-Burga
- University College London Great Ormond Street Institute of Child Health, GOSH NIHR BRC, London WC1N 1EH, UK
- Carlo Giaquinto
- Division of Pediatric Infectious Diseases, Department for Woman and Child Health, University of Padova, 35122 Padova, Italy
- María José Mellado-Peña
- Department of Paediatrics, Hospital Universitario La Paz, 28046 Madrid, Spain
- Alfredo García-Alix
- Fundació NeNe, 28010 Madrid, Spain
- Elena Carreras
- Unit of Fetal Medicine, Department of Obstetrics, Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain
- Pere Soler-Palacín
- Paediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
- DOI
- https://doi.org/10.3390/pathogens9050352
- Journal volume & issue
-
Vol. 9,
no. 5
p. 352
Abstract
Background: Zika virus (ZIKV) infection has been associated with congenital microcephaly and other neurodevelopmental abnormalities. There is little published research on the effect of maternal ZIKV infection in a non-endemic European region. We aimed to describe the outcomes of pregnant travelers diagnosed as ZIKV-infected in Spain, and their exposed children. Methods: This prospective observational cohort study of nine referral hospitals enrolled pregnant women (PW) who travelled to endemic areas during their pregnancy or the two previous months, or those whose sexual partners visited endemic areas in the previous 6 months. Infants of ZIKV-infected mothers were followed for about two years. Results: ZIKV infection was diagnosed in 163 PW; 112 (70%) were asymptomatic and 24 (14.7%) were confirmed cases. Among 143 infants, 14 (9.8%) had adverse outcomes during follow-up; three had a congenital Zika syndrome (CZS), and 11 other potential Zika-related outcomes. The overall incidence of CZS was 2.1% (95%CI: 0.4–6.0%), but among infants born to ZIKV-confirmed mothers, this increased to 15.8% (95%CI: 3.4–39.6%). Conclusions: A nearly 10% overall risk of neurologic and hearing adverse outcomes was found in ZIKV-exposed children born to a ZIKV-infected traveler PW. Longer-term follow-up of these children is needed to assess whether there are any later-onset manifestations.
Keywords